Related Experiment Video
Updated: May 5, 2026
08:12
Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
13.1K
Digitalis in acute myocardial infarction: help or hazard?
Annals of Internal Medicine
|February 1, 1975
Summary
Digitalis use in acute myocardial infarction is debated, but evidence does not support increased arrhythmias. It improves left ventricular function and reduces cardiac workload, especially in heart failure.
Area of Science:
- Cardiology
- Pharmacology
Background:
- The role of digitalis in acute myocardial infarction (AMI) is controversial due to debated risks and benefits.
- Concerns exist regarding electrophysiologic, hemodynamic, and metabolic effects of digitalis in AMI.
Purpose of the Study:
- To evaluate the risks and benefits of digitalis in patients with acute myocardial infarction.
- To clarify the impact of digitalis on arrhythmias, left ventricular function, and infarct size.
Main Methods:
- Review of existing evidence on digitalis therapy in acute myocardial infarction.
- Analysis of data on electrophysiologic, hemodynamic, and metabolic effects.
- Assessment of left ventricular function and infarct size changes.
Main Results:
- No convincing evidence suggests increased arrhythmias with digitalis therapy in AMI.
- Direct measurements show improved impaired left ventricular performance.
- Metabolic costs are offset by reduced cardiac workload, particularly in heart failure.
Conclusions:
- Digitalis may be recommended for acute myocardial infarction when supraventricular tachyarrhythmias or cardiac failure are present.
- Potential risks like infarct extension may be model-specific or absent in cardiac failure.
More Related Videos
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
10.8K
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.9K
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:14Myocarditis III: Medical Management
344
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
01:28Acute Coronary Syndrome IV: Interprofessional Care
525
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
01:30Heart Failure V: Medical Management
641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
01:30Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810